Autophagic Rationing Drives Selective Loss of Vocal Fold Biosynthetic Capacity in Presbyphonia
Hypothesis
In aging vocal folds, chronic subclinical inflammation creates a siege‑like metabolic state that constitutively activates autophagy transcriptional programs while lysosomal dysfunction blocks flux completion. This mismatch forces the cell to rationally dismantle non‑essential biosynthetic machinery—particularly ER‑associated ribosomes and rough endoplasmic reticulum—through selective ER‑phagy, thereby reducing synthesis of extracellular matrix proteins (collagen, elastin) and accelerating the fibro‑fatty atrophy seen in presbyphonia. Mitochondrial ribosomes are spared to preserve ATP for survival.
Mechanistic Rationale
- Transcription‑flux uncoupling: Cholesterol depletion and aging‑related TFEB/FOXO dysregulation increase ATG gene transcription 1 2 but lysosomal acidification and cathepsin activity decline, yielding high LC3‑II puncta with accumulated p62—a signature of incomplete autophagy.
- Selective cargo preference: Inflammation‑induced muscle atrophy shows preferential autophagy of ER and cytosolic ribosomes while sparing mitochondrial ribosomes 4; we hypothesize a similar hierarchy in vocal fold fibroblasts where ER‑phagy receptors (e.g., FAM134B, SEC62) are up‑regulated, targeting the secretory pathway responsible for ECM protein production.
- Energetic triage: By consuming ER membranes and ribosomes, the cell liberates amino acids and lipids for immediate energy needs, sustaining basal mitochondrial function and preventing apoptotic death despite chronic nutrient‑signaling stress.
- ECM consequence: Reduced ER capacity diminishes translation of procollagen and tropoelastin, leading to the thin, disorganized lamina propria observed histologically 6; concomitant fatty infiltration reflects redirected lipid storage when biosynthetic output falls.
Testable Predictions
- Molecular signature: Aged human vocal fold fibroblasts will exhibit elevated ATG5, ATG7, LC3B mRNA but reduced autophagic flux (lower LC3‑II/I ratio after bafilomycin A1, higher p62) compared with young cells.
- Selective ribosome loss: ER‑associated ribosomal protein RPL7A will be significantly decreased, whereas mitochondrial ribosomal protein MRPL12 remains unchanged.
- ECM synthesis link: Collagen Iα1 and elastin mRNA and protein secretion will correlate inversely with ER‑phagy activity (measured by FAM134B‑positive puncta).
- Rescue experiment: Pharmacological lysosomal activation (e.g., TFEB overexpression) or genetic inhibition of ER‑phagy (siRNA against FAM134B) will restore flux, increase ER ribosome levels, and augment collagen/elastin production without increasing apoptosis.
Potential Experiments
- Obtain vocal fold biopsies from donors stratified by age (20‑35 yr vs >65 yr). Isolate fibroblasts and perform qPCR for ATG genes, Western blot for LC3‑II/I and p62 ± bafilomycin A1, immunofluorescence for LC3 puncta and FAM134B.
- Ribosome fractionation: isolate ER‑bound vs mitochondrial ribosomes, quantify RPL7A and MRPL12 by mass spectrometry or qPCR.
- Measure secreted collagen I and elastin via ELISA and Sirius Red staining; correlate with ER‑phagy indices.
- Intervene: transfect aged fibroblasts with TFEB‑adenovirus or treat with trehalose to enhance lysosomal function; alternatively, knock down FAM134B. Assess flux rescue, ribosome content, and ECM output.
- Functional test: embed treated fibroblasts in 3‑dimensional collagen gels and assess contractility and matrix remodeling as a proxy for vocal fold biomechanics.
Falsifiability: If aged vocal fold fibroblasts show autophagy flux comparable to young cells (i.e., LC3‑II/I increases with bafilomycin and p62 decreases) or if ER ribosome levels are unchanged while mitochondrial ribosomes are degraded, the siege‑rationing model would be refuted.